Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Atrial Fibrillation Market

4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Atrial Fibrillation Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Key Industry Developments
5.2. Disease Prevalence & Incidence Rate, by Region/Globally
5.3. Atrial Fibrillation Overview
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Atrial Fibrillation Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2031
6.3.1. Pharmacological Treatment
6.3.1.1. Anti-arrhythmic Drugs
6.3.1.2. Anti-coagulant Drugs
6.3.2. Non-pharmacological Treatment
6.3.2.1. Catheter Ablation
6.3.2.1.1. Radiofrequency Based
6.3.2.1.2. Cryoablation Based
6.3.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
6.3.2.1.4. Microwave Based
6.3.2.1.5. Laser Based
6.3.2.2. Maze Surgery
6.3.2.3. Electric Cardioversion
6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Atrial Fibrillation Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region

8. North America Atrial Fibrillation Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Treatment Type, 2017–2031
8.2.1. Pharmacological Treatment
8.2.1.1. Anti-arrhythmic Drugs
8.2.1.2. Anti-coagulant Drugs
8.2.2. Non-pharmacological Treatment
8.2.2.1. Catheter Ablation
8.2.2.1.1. Radiofrequency Based
8.2.2.1.2. Cryoablation Based
8.2.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
8.2.2.1.4. Microwave Based
8.2.2.1.5. Laser Based
8.2.2.2. Maze Surgery
8.2.2.3. Electric Cardioversion
8.3. Market Value Forecast, by Country, 2017–2031
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Treatment Type
8.4.2. By Country

9. Europe Atrial Fibrillation Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Treatment Type, 2017–2031
9.2.1. Pharmacological Treatment
9.2.1.1. Anti-arrhythmic Drugs
9.2.1.2. Anti-coagulant Drugs
9.2.2. Non-pharmacological Treatment
9.2.2.1. Catheter Ablation
9.2.2.1.1. Radiofrequency Based
9.2.2.1.2. Cryoablation Based
9.2.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
9.2.2.1.4. Microwave Based
9.2.2.1.5. Laser Based
9.2.2.2. Maze Surgery
9.2.2.3. Electric Cardioversion
9.3. Market Value Forecast, by Country/Sub-region, 2017–2031
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Treatment Type
9.4.2. By Country/Sub-region

10. Asia Pacific Atrial Fibrillation Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2017–2031
10.2.1. Pharmacological Treatment
10.2.1.1. Anti-arrhythmic Drugs
10.2.1.2. Anti-coagulant Drugs
10.2.2. Non-pharmacological Treatment
10.2.2.1. Catheter Ablation
10.2.2.1.1. Radiofrequency Based
10.2.2.1.2. Cryoablation Based
10.2.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
10.2.2.1.4. Microwave Based
10.2.2.1.5. Laser Based
10.2.2.2. Maze Surgery
10.2.2.3. Electric Cardioversion
10.3. Market Value Forecast, by Country/Sub-region, 2017–2031
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Treatment Type
10.4.2. By Country/Sub-region

11. Latin America Atrial Fibrillation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017–2031
11.2.1. Pharmacological Treatment
11.2.1.1. Anti-arrhythmic Drugs
11.2.1.2. Anti-coagulant Drugs
11.2.2. Non-pharmacological Treatment
11.2.2.1. Catheter Ablation
11.2.2.1.1. Radiofrequency Based
11.2.2.1.2. Cryoablation Based
11.2.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
11.2.2.1.4. Microwave Based
11.2.2.1.5. Laser Based
11.2.2.2. Maze Surgery
11.2.2.3. Electric Cardioversion
11.3. Market Value Forecast, by Country/Sub-region, 2017–2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Treatment Type
11.4.2. By Country/Sub-region

12. Middle East & Africa Atrial Fibrillation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017–2031
12.2.1. Pharmacological Treatment
12.2.1.1. Anti-arrhythmic Drugs
12.2.1.2. Anti-coagulant Drugs
12.2.2. Non-pharmacological Treatment
12.2.2.1. Catheter Ablation
12.2.2.1.1. Radiofrequency Based
12.2.2.1.2. Cryoablation Based
12.2.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
12.2.2.1.4. Microwave Based
12.2.2.1.5. Laser Based
12.2.2.2. Maze Surgery
12.2.2.3. Electric Cardioversion
12.3. Market Value Forecast, by Country/Sub-region, 2017–2031
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Treatment Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Company Profiles
13.2.1. Agilent Technologies, Inc.
13.2.1.1. Company Overview
13.2.1.2. Business Overview
13.2.1.3. Financial Overview
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2. Allied Healthcare Products, Inc.
13.2.2.1. Company Overview
13.2.2.2. Business Overview
13.2.2.3. Financial Overview
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. CareFusion Corporation
13.2.3.1. Company Overview
13.2.3.2. Business Overview
13.2.3.3. Financial Overview
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4. Covidien plc
13.2.4.1. Company Overview
13.2.4.2. Business Overview
13.2.4.3. Financial Overview
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5. GE Healthcare Ltd.
13.2.5.1. Company Overview
13.2.5.2. Business Overview
13.2.5.3. Financial Overview
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6. GF Health Products, Inc.
13.2.6.1. Company Overview
13.2.6.2. Business Overview
13.2.6.3. Financial Overview
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7. Omron Healthcare, Inc.
13.2.7.1. Company Overview
13.2.7.2. Business Overview
13.2.7.3. Financial Overview
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8. PARI Respiratory Equipment, Inc.
13.2.8.1. Company Overview
13.2.8.2. Business Overview
13.2.8.3. Financial Overview
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview
13.2.9. Philips Healthcare
13.2.9.1. Company Overview
13.2.9.2. Business Overview
13.2.9.3. Financial Overview
13.2.9.4. SWOT Analysis
13.2.9.5. Strategic Overview



List of Figures

List of Figure
Figure 1: Global Atrial Fibrillation Market Size (US$ Mn) Forecast, 2017–2031
Figure 2: Global Atrial Fibrillation Market Value Share, by Treatment Type, 2021
Figure 3: Global Atrial Fibrillation Market Value Share, by Region, 2021
Figure 4: Global Molecular Diagnostic Market Attractiveness Analysis, by Treatment Type, 2021
Figure 5: Global Pharmacological Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2031
Figure 6: Global Non-pharmacological Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2031
Figure 7: Global Atrial Fibrillation Market Attractiveness Analysis, by Region, 2022–2031
Figure 8: North America Atrial Fibrillation Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 9: North America Atrial Fibrillation Market Attractiveness Analysis, by Country, 2022–2031
Figure 10: North America Market Value Share Analysis, by Technology Type, 2017 and 2031
Figure 11: North America Market Attractiveness Analysis, by Technology Type, 2022 and 2031
Figure 12: North America Market Value Share Analysis, by Country, 2017 and 2031
Figure 13: North America Market Attractiveness Analysis, by Technology, 2022–2031
Figure 14: Europe Atrial Fibrillation Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 15: Europe Atrial Fibrillation Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 16: Europe Market Value Share Analysis, by Technology Type, 2017 and 2031
Figure 17: Europe Market Attractiveness Analysis, by Technology Type, 2017 and 2031
Figure 18: Europe Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 19: Europe Market Attractiveness Analysis, by Technology, 2022–2031
Figure 20: Asia Pacific Atrial Fibrillation Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 21: Asia Pacific Atrial Fibrillation Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 22: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2031
Figure 23: Asia Pacific Market Attractiveness Analysis, by Technology Type, 2017 and 2031
Figure 24: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 25: Asia Pacific Market Attractiveness Analysis, by Technology, 2022–2031
Figure 26: Latin America Atrial Fibrillation Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 27: Latin America Atrial Fibrillation Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 28: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2031
Figure 29: Latin America Market Attractiveness Analysis, by Technology Type, 2017 and 2031
Figure 30: Latin America Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 31: Latin America Market Attractiveness Analysis, by Technology, 2022–2031
Figure 32: Middle East & Africa Atrial Fibrillation Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 33: Middle East & Africa Atrial Fibrillation Market Attractiveness Analysis, by Country/Sub-region, 2020
Figure 34: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2031
Figure 35: Middle East & Africa Market Attractiveness Analysis, by Technology Type, 2017 and 2031
Figure 36: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 37: Middle East & Africa Market Attractiveness Analysis, by Technology, 2022–2031

List of Tables

List of Table
Table 1: Global Atrial Fibrillation Market Size (US$ Mn) Forecast, 2017–2031
Table 2: Global Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 3: Global Atrial Fibrillation Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 4: North America Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology Type, 2017–2031
Table 5: North America Atrial Fibrillation Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 6: Europe Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology Type, 2017–2031
Table 7: Europe Atrial Fibrillation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 8: Asia Pacific Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology Type, 2017–2031
Table 9: Asia Pacific Atrial Fibrillation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Latin America Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology Type, 2017–2031
Table 11: Latin America Atrial Fibrillation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Middle East & Africa Atrial Fibrillation Market Size (US$ Mn) Forecast, by Technology Type, 2017–2031
Table 13: Middle East & Africa Atrial Fibrillation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031